Clinical Trial Update: Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Breast Cancer [EARLY_Phase 1]

View source ↗

Summary

An EARLY Phase 1 trial is evaluating a Gallium-68 labeled CD73-targeting PET/CT imaging probe for diagnosing breast cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 68Ga-labeled CD73 targeting probe (CD73-targeting PET/CT imaging probe)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Breast Cancer | EARLY_Phase 1 | Status: RECRUITING